Noninvasive respiratory support in acute hypoxemic respiratory failure associated with COVID-19 and other viral infections

Risultato della ricerca: Article

Abstract

Noninvasive respiratory support (NRS) such as noninvasive ventilation (NIV) and high flow nasal therapy (HFNT) have been used in the treatment of acute hypoxemic respiratory failure (AHRF) related to the coronavirus disease (COVID-19) and other viral infections. However, there is a lack of consensus in favor of or against NRS use due to the risks of worsening hypoxemia, intubation delay, and aerosols environmental contamination associated with the use of these tools. We aimed to summarize the evidence on the use of NRS in adult patients with COVID-19 and other viral pneumonia (i.e. H1N1, SARS, MERS) and AHRF. We also searched for studies evaluating the risk of aerosolization/contamination with these tools.
Lingua originaleEnglish
Numero di pagine35
RivistaMinerva Anestesiologica
Stato di pubblicazionePublished - 2020

Fingerprint Entra nei temi di ricerca di 'Noninvasive respiratory support in acute hypoxemic respiratory failure associated with COVID-19 and other viral infections'. Insieme formano una fingerprint unica.

  • Cita questo